This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Clinical Spectrum and Outcome of Neonatal Multi-System Inflammatory Syndrome (MIS-N) - A Prospective Cohort Study. (preprint)
authorea preprints; 2022.
Preprint
in English
| PREPRINT-AUTHOREA PREPRINTS | ID: ppzbmed-10.22541.au.166979176.66104074.v1
ABSTRACT
AIMS:
To analyze the clinical spectrum in Neonates with MIS-N based on the time of presentation and also to assess the use of immunomodulator therapy in MIS-N. SUBJECTS ANDMETHODS:
We studied 100 neonates, delivered at BLDE (DU) Shri B M Patil Medical College Hospital admitted to Level III-A NICU from JULY 2020 to MAY 2021. 98 neonates had high titers of Ig G antibodies and negative for COVID Antigen. We categorized the cohorts into EARLY MIS-N (<72 hrs) and LATE MIS-N (>72 hrs).RESULTS:
58 presented as EARLY MIS-N with Respiratory Distress in 40 (70%), cardiac dysfunction 34 (60%), PPHN 12(20%), Fever 12(20%), seizures 12(20%), encephalopathy in 6(10%), sepsis-like features 6(10%), had elevated inflammatory markers like CRP (30%), D-Dimer (70%), Ferritin (30%), cardiac biomarkers like BNP (60%), LDH (30%) and ECHO showing LV dysfunction in 50%. LATE MIS-N presented mostly with fever 28(70%), sepsis-like features 24(60%), Respiratory Distress in 16(40%), cardiac dysfunction 12 (30%), hypoglycemia 4(10%) parotitis 4(10%), had significantly elevated inflammatory markers like CRP (70%), D-Dimer (50%), Ferritin (70%), cardiac biomarkers like BNP (40%), LDH (20%) and ECHO showing LV dysfunction in 20%, dilated coronaries in 20 %, PPHN in 10%. Oxygen and respiratory support requirement was more in EARLY presenters and IVIG and steroid requirement was more in LATE presenters.CONCLUSION:
We observed that maternal SARS COV2 antibodies transferred transplacentally and neonatal antibodies acquired after COVID 19 infection can cause MIS-N in neonates. The immunomodulator therapy is required in severe cases of MIS-N only.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-AUTHOREA PREPRINTS
Main subject:
Parotitis
/
Respiratory Distress Syndrome
/
Seizures
/
Sexual Dysfunction, Physiological
/
Brain Diseases
/
Dementia, Multi-Infarct
/
Sepsis
/
Fever
/
Heart Diseases
/
Hypoglycemia
Language:
English
Year:
2022
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS